<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The purpose of our study was to determine whether inhibiting the action of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (TNFalpha) attenuates brain injury and reduces <z:mp ids='MP_0001845'>inflammatory responses</z:mp> in the mouse during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and reperfusion </plain></SENT>
<SENT sid="1" pm="."><plain>Mice underwent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) for 1 h followed by 23 h reperfusion </plain></SENT>
<SENT sid="2" pm="."><plain>Monoclonal neutralizing anti-murine TNFalpha antibody (mAb) was administrated intraventricularly in the mouse with temporary MCAO </plain></SENT>
<SENT sid="3" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume in the anti-TNFalpha mAb treated mice was significantly smaller than that in the control group (p &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>The number of intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 (ICAM-1)-positive vessels in the ischemic area of the anti-TNFalpha mAb-treated group was significantly less than that in the control group </plain></SENT>
<SENT sid="5" pm="."><plain>Our study demonstrated that blocking TNFalpha reduced brain injury and attenuated ICAM-1 expression during transient <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>